Research output: Contribution to journal › Article › peer-review
23Citations
(Web of Science)
Fingerprint
Dive into the research topics of 'PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)'. Together they form a unique fingerprint.